Exploration of the key active ingredients and mechanisms of Sparganii Rhizoma-Curcumae Rhizoma compatible formulation against human colorectal cancer through network pharmacology and in vitro experiments

• Main Authors: Hongyan Lin (Author), Dongxuan Ai (Author), Xinling Wang (Author), Shuaijun Cui (Author), Xinghong Li (Author), Bangmei Ye (Author), Lingyu Ruan (Author), Jing Xu (Author), Liqun Wang (Author)
• Format: Book
• Published: Elsevier, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Sparganii Rhizoma-Curcumae Rhizoma (SR-CR) formulation may offer an effective treatment for human colorectal cancer (CRC). However, the active ingredients and underlying mechanisms of this herbal formulation remain unclear. Methods: This study integrates network pharmacology, molecular...